This study examined the impact of Artemisia argyi extract (AE) on bone health using a mouse model of ovariectomy (OVX)-induced osteoporosis. A total of seven sham-operated mice and twenty-one OVX mice were assigned to three groups: control (OVX), estradiol-treated (E2, 10 μg/kg), and AE-treated (100 mg/kg). The treatment lasted for 12 weeks, during which body weight, food intake, hindlimb thickness, grip strength, and various bone parameters were recorded. Dual-energy X-ray absorptiometry (DXA) was employed to evaluate body composition, bone mineral content (BMC), and bone mineral density (BMD). The administration of AE significantly increased BMC and BMD compared to the OVX group, with no notable changes in body composition. Although AE did not enhance hindlimb thickness, it did significantly improve grip strength. These findings indicate that AE selectively promotes bone metabolism and may serve as a potential functional food component for preventing osteoporosis in postmenopausal women.